Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
J Clin Oncol
; 39(7): 822-835, 2021 03 01.
Article
in En
| MEDLINE
| ID: mdl-33405951
Full text:
1
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Cerebellar Neoplasms
/
DNA Methylation
/
Medulloblastoma
/
Mutation
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Clin Oncol
Year:
2021
Type:
Article
Affiliation country:
Tunisia